Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
Stopped early · Not applicable
Conditions studied: Seborrheic Dermatitis
In brief
The goal of this research is to demonstrate the use of petroleum jelly in prevention of nonscalp seborrheic dermatitis exacerbations at the first signs of a flare. In doing so, it will decrease the chronic use of topical steroids. The use of petrolatum should have favorable outcomes for patients, without the side-effects.
Key facts
- Study ID
- NCT01315951
- Run by
- Ascension Health
- People needed
- 3
- Starts
- 2011-03-01
- Expected to finish
- 2012-03-01
- Last updated by the study team
- 2024-05-20
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18-75 years old who are patients of the Genesys East Flint Clinic and have been diagnosed with recurrent NSSD
- Patients are to use the petrolatum treatment strictly for the initial symptoms of NSSD: Excessive flaking, and erythematous macules or papules
- Patients who are able to attend the follow-up appointments for assessment
- Patients are to have the doctor's confidence that that patient will correctly implement the treatment plan
You may not qualify if…
- Patients not in the 18-75 years of age range.
- Patients who are receiving treatment for their seborrheic dermatitis (Scalp or nonscalp) elsewhere.
- Patients who have not demonstrated recurrent NSSD.
- Patients who are unable to commit to a follow-up appointments for assessment.
- Patients who do not have the physician's confidence in implementing the studies treatment plan effectively.
- Patient's who are unable/unwilling to have petrolatum on affected area for at least a 6 hour length of time.
Where it is running
- Genesys East Flint Campus — Burton, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.